Suivre
Payam Peymani
Payam Peymani
Pharm.D, PhD, Lead Research Associate, College of Pharmacy, University of Manitoba
Adresse e-mail validée de umanitoba.ca
Titre
Citée par
Citée par
Année
Health in the Islamic Republic of Iran, challenges and progresses
KB Lankarani, SM Alavian, P Peymani
Medical journal of the Islamic Republic of Iran 27 (1), 42, 2013
2112013
Quantum dot: magic nanoparticle for imaging, detection and targeting
Y Ghasemi, P Peymani, S Afifi
Acta Biomed 80 (2), 156-165, 2009
1982009
The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
M Akbari, M Ghayour-Mobarhan, G Ferns, Z Asemi
Frontiers in pharmacology 10, 439144, 2019
1252019
Epidemiological characteristics of fatal traffic accidents in Fars province, Iran: a community-based survey
ST Heydari, A Hoseinzadeh, F Ghaffarpasand, A Hedjazi, M Zarenezhad, ...
Public health 127 (8), 704-709, 2013
882013
Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response
B Yeganeh, AR Moghadam, J Alizadeh, E Wiechec, SM Alavian, ...
World journal of gastroenterology 21 (47), 13225, 2015
792015
Fatal motorcycle accidents in Fars Province, Iran: a community-based survey
TH Seyed, M Najmeh, F Ali, S Yaser, G Fariborz, H Arya, Z Mohammad, ...
Chinese journal of traumatology 15 (04), 222-227, 2012
722012
Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review
M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ...
Expert Opinion on Drug Safety 19 (2), 167-186, 2020
642020
The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in …
R Tabrizi, V Ostadmohammadi, M Akbari, KB Lankarani, S Vakili, ...
Probiotics and antimicrobial proteins, 1-14, 2019
642019
The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials
R Tabrizi, V Ostadmohammadi, KB Lankarani, P Peymani, M Akbari, ...
Lipids in health and disease 17, 1-11, 2018
622018
Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
P Peymani, T Dehesh, F Aligolighasemabadi, M Sadeghdoust, K Kotfis, ...
Translational medicine communications 6, 1-14, 2021
582021
Epidemiological characteristics of fatal pedestrian accidents in Fars Province of Iran: a community-based survey
P Payam, TH Seyed, H Amin, S Yaser, H Arya, Z Mohammad, M Ghasem, ...
Chinese journal of traumatology 15 (05), 279-283, 2012
572012
The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review …
R Tabrizi, OR Tamtaji, KB Lankarani, N Mirhosseini, M Akbari, ...
Food & function 9 (12), 6116-6128, 2018
492018
Time analysis of fatal traffic accidents in Fars Province of Iran
TH Seyed, H Amin, S Yaser, H Arya, Z Mohammad, M Ghasem, ...
Chinese journal of traumatology 16 (02), 84-88, 2013
482013
Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study
KB Lankarani, M Mahmoodi, M Lotfi, N Zamiri, ST Heydari, ...
Korean J Gastroenterol 62 (6), 344-351, 2013
462013
The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled …
R Tabrizi, OR Tamtaji, N Mirhosseini, KB Lankarani, M Akbari, ...
Pharmacological Research 141, 85-103, 2019
452019
Evaluation of the sensitivity and reliability of primary rainbow trout hepatocyte vitellogenin expression as a screening assay for estrogen mimics: methodological issues
S Sabour, F Farzaneh, P Peymani
Aquatic Toxicology 164, 175-176, 2015
442015
New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
P Peymani, B Yeganeh, S Sabour, B Geramizadeh, MR Fattahi, ...
Canadian journal of physiology and pharmacology 94 (6), 613-619, 2016
422016
Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran
S Afifi, N Maharloui, P Peymani, S Namazi, AG Gharaei, P Jahani, ...
International Journal of Risk & Safety in Medicine 26 (3), 139-145, 2014
312014
THE PREVALENCE OF HIGH BLOOD PRESSURE AND ITS RELATIONSHIP WITH ANTHROPOMETRIC INDICATORS, A POPULATION BASED STUDY IN FARS PROVINCE, IR IRAN
P Peymani, ST Heydari, SM Ahmadi, Y Sarikhani, H Joulaei, ...
INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL 6 (219), 40-45, 2012
312012
Evaluation of factors that influenced the length of hospital stay using data mining techniques
M Eskandari, AH Alizadeh Bahmani, HA Mardani-Fard, I Karimzadeh, ...
BMC Medical Informatics and Decision Making 22 (1), 280, 2022
272022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20